Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Assessing Developability and Designing Advanceable Formulations from the Start
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Discussing the Advancements in Oncology
Disaster Strikes
The Evolving Role of Remote Monitoring
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Sailing into the Trade Winds
Transforming Market Insights into Growth
Preparing the Yacht for the Race
Building Multiple Platforms to Address Difficult-to-Treat Cancers
The Power of Aqueous Detergents in Critical Cleaning
Designing A Recipe for Stem Cell Therapy Success
Growing as a Trusted, Dedicated Commercial Biologics CDMO
Assembling the Crew
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Assessing Developability and Designing Advanceable Formulations from the Start
Building a Path to Approval with Effective Regulatory Support
Rethinking the Conventional CDMO Model
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform
Breakthrough Results for Jardiance® (Empagliflozin) Confirm Emperor-preserved as First and Only Successful Trial for Heart Failure with Preserved Ejection Fraction
Olon Continues its Growth Path and Announces a New Acquistion
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.